Skip to main content

Edelman Joseph's Form 4 filing

Chembio Diagnostics, Inc. (CEMI) · filed Apr 17, 2023

Accession no.
0000899243-23-011334
Filed
Apr 17, 2023, 8:47 PM ET
Trade date
Apr 13-17, 2023
Filing delay
4 days
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions. Open-market purchases total $70.4K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Edelman JosephCIK 000116442610% Owner
Perceptive Advisors LLCCIK 000122496210% Owner
Perceptive Credit Advisors, LLCCIK 000187708110% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Apr 13, 2023Common StockPPurchaseAcquired+140,134$0.45F1+$63,060.34,694,234Indirect
Apr 14, 2023Common StockPPurchaseAcquired+11,500$0.45F2+$5,1754,705,734Indirect
Apr 17, 2023Common StockPPurchaseAcquired+4,800$0.45F3+$2,1604,710,534Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.446 to $0.448, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges of the prices reported.

Referenced by the price of 1 transaction in Table I.

F2

The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.4472 to $0.448, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges of the prices reported.

Referenced by the price of 1 transaction in Table I.

F3

The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.4479 to $0.448, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges of the prices reported.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)